Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study

Blood(2022)

引用 13|浏览4
暂无评分
关键词
multiple myeloma,subcutaneous daratumumab,teclistamab,lenalidomide,multicohort study
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要